Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-076635
Filing Date
2025-08-14
Accepted
2025-08-14 16:06:33
Documents
92
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0252758-10q_immucell.htm   iXBRL 10-Q 1163221
2 CERTIFICATION ea025275801ex31-1_immucell.htm EX-31.1 6781
3 CERTIFICATION ea025275801ex31-2_immucell.htm EX-31.2 6864
4 CERTIFICATION ea025275801ex32-1_immucell.htm EX-32.1 4253
5 CERTIFICATION ea025275801ex32-2_immucell.htm EX-32.2 4214
  Complete submission text file 0001213900-25-076635.txt   7334609

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE iccc-20250630.xsd EX-101.SCH 58254
7 XBRL CALCULATION FILE iccc-20250630_cal.xml EX-101.CAL 42183
8 XBRL DEFINITION FILE iccc-20250630_def.xml EX-101.DEF 306928
9 XBRL LABEL FILE iccc-20250630_lab.xml EX-101.LAB 562718
10 XBRL PRESENTATION FILE iccc-20250630_pre.xml EX-101.PRE 332509
95 EXTRACTED XBRL INSTANCE DOCUMENT ea0252758-10q_immucell_htm.xml XML 1050406
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 251218856
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)